21 results on '"van Werkhoven E"'
Search Results
2. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
3. Prospective experimental treatment of colorectal cancer patients based on organoid drug responses
4. Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
5. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)
6. Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group
7. The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies
8. Response to induction chemotherapy and surgery in non-organ confined bladder cancer: A single institution experience
9. 1261P Trastuzumab/pertuzumab combination therapy in advanced pre-treated HER2-mutated non-small cell lung cancer: Results of a DRUP trial cohort
10. 594P The Drug Rediscovery Protocol (DRUP): Results of the first 500 treated patients
11. LBA27 - Drug Rediscovery Protocol: Expanded use of existing anticancer drugs
12. 618P - Updated survival analysis of the randomized phase III trial comparing S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (SALTO) by the Dutch colorectal cancer group
13. 187P - High dose neo-adjuvant chemotherapy in triple-negative breast cancer with evidence of homologous recombination deficiency (HRD)
14. Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients
15. 452O - DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD*2A, c.2846A>T, c.1679T>G and c.1236G>A
16. 303 (PB-098) - Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
17. 20 - Omitting sentinel lymph node biopsy after neoadjuvant systemic therapy in selected breast cancer patients with clinical node-negative disease
18. 5 - The influence of the boost dose on cosmetic outcome after breast conserving therapy: Results of the Young Boost Trial
19. LBA14 - Adaptive phase II randomized non-comparative trial of nivolumab after induction treatment in triple negative breast cancer: TONIC-trial
20. 2BA - Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group
21. 4233 The impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on the experienced Quality of Life during the first two months after procedure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.